HIIT may boost muscle sugar storage and cut liver fat in type 2 diabetes

NCT ID NCT06688461

First seen Mar 30, 2026 · Last updated Jun 23, 2026 · Updated 17 times

Summary

This study tests whether 12 weeks of high-intensity interval training (HIIT) can improve how muscles store sugar (glycogen) and use insulin in people with type 2 diabetes. Researchers will also check if HIIT reduces liver fat. The trial involves 36 overweight or obese adults aged 45-75 with type 2 diabetes. Participants will do HIIT three times per week, and their insulin sensitivity and liver fat will be measured before and after the program.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Finis Terrae University

    RECRUITING

    Santiago, Chile

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

High-intensity interval training (HIIT) exercise program

What this could lead to

If it works, this could show that HIIT is a better exercise strategy to improve blood sugar control and reduce liver fat in type 2 diabetes patients.

What could go wrong

This is a small, early-phase study with only 36 participants. The results may not apply to all people with type 2 diabetes, and the exercise program may be too intense for some.

Conditions

The condition(s) this trial relates to.

Insulin Resistance psychiatric disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.